Add-on Acquisition • Life Science

Phadia AB Acquires Allergon AB

On January 1, 1971, Phadia AB acquired life science company Allergon AB

Acquisition Context

This is Phadia AB’s 1st transaction in the Life Science sector.
This is Phadia AB’s 1st transaction in Sweden.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	January 1, 1971
Target	Allergon AB
Sector	Life Science
Buyer(s)	Phadia AB
Deal Type	Add-on Acquisition

Target Company

Allergon AB

Ängelholm, Sweden

Allergon AB is a Swedish company that will become a world's major producer of allergen source material and a cornerstone in Pharmacia Diagnostics’ allergy tests.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Phadia AB

Uppsala, Sweden

Category	Company
Founded	2004
Sector	Healthcare Services
Revenue	380M EUR (2013)

DESCRIPTION

Phadia AB,a provider in in-vitro allergy diagnostics and the European leader in autoimmunity diagnostics. It has a global footprint, distributing directly in 21 territories and enjoying further reach through a broad international network of distributors. The company is headquartered in Uppsala, Sweden, and employs over 1,100 people worldwide.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
Country: Sweden	1 of 1
Year: 1971	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Sweden M&A